Australia's most trusted
source of pharma news
Wednesday, 18 February 2026
Posted 17 February 2026 PM
Australian pharma executives are stepping into big leadership roles, either switching companies or winning internal promotions.
Former AstraZeneca Director Clinical Research Julie Ince-Demetriou has landed the CEO role at privately owned Australian Clinical Research Organisation Molecule2Market as it enters a new chapter of growth.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.